Literature DB >> 34360046

Increased Transmissibility of the SARS-CoV-2 Alpha Variant in a Japanese Population.

Hideo Tanaka1, Atsushi Hirayama2, Hitomi Nagai3, Chika Shirai4, Yuki Takahashi1, Hiroto Shinomiya5, Chie Taniguchi6, Tsuyoshi Ogata7.   

Abstract

To assess the relative transmissibility of the SARS-CoV-2 Alpha variant compared to the pre-existing SARS-CoV-2 in Japan, we performed a cross-sectional study to determine the secondary attack rate of COVID-19 in household contacts before and after the Alpha variant became dominant in Osaka. We accessed 290 household contacts whose index cases were diagnosed between 1 and 20 December 2020 (the third epidemic group), at a time when Osaka was free of the Alpha variant. We also accessed 398 household contacts whose index cases were diagnosed between 20 April and 3 May 2021 (the fourth epidemic group), by which time the Alpha variant had become dominant. We identified 124 household contacts whose index case was determined positive for the Alpha variant (Alpha group) in this fourth group. The secondary attack rates in the fourth group (34.7%) and the Alpha group (38.7%) were significantly higher than that in the third group (19.3%, p < 0.001). Multivariable Poisson regression analysis with a robust error variance showed a significant excess risk in the fourth group (1.90, 95% CI = 1.47-2.48) and the Alpha group (2.34, 95% CI = 1.71-3.21). This finding indicates that the SARS-CoV-2 Alpha variant has an approximately 1.9-2.3-fold higher transmissibility than the pre-existing virus in the Japanese population.

Entities:  

Keywords:  Alpha variant; Japanese; N501Y; SARS-CoV-2; household contact; transmissibility

Year:  2021        PMID: 34360046     DOI: 10.3390/ijerph18157752

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  13 in total

1.  Temporal trends in clinical characteristics and in-hospital mortality among patients with COVID-19 in Japan for waves 1, 2, and 3: A retrospective cohort study.

Authors:  Hideki Endo; Kyunghee Lee; Tetsu Ohnuma; Senri Watanabe; Kiyohide Fushimi
Journal:  J Infect Chemother       Date:  2022-06-29       Impact factor: 2.065

Review 2.  SARS-CoV-2 Transmission and Prevention in the Era of the Delta Variant.

Authors:  Eric A Meyerowitz; Aaron Richterman
Journal:  Infect Dis Clin North Am       Date:  2022-02-01       Impact factor: 5.905

Review 3.  SARS-CoV-2: Evolution and Emergence of New Viral Variants.

Authors:  Verónica Roxana Flores-Vega; Jessica Viridiana Monroy-Molina; Luis Enrique Jiménez-Hernández; Alfredo G Torres; José Ignacio Santos-Preciado; Roberto Rosales-Reyes
Journal:  Viruses       Date:  2022-03-22       Impact factor: 5.818

4.  Treatment and outcome of COVID-19 patients in a specialized hospital during the third wave: advance of age and increased mortality compared with the first/second waves.

Authors:  Yutaka Oda; Motoko Shimada; Satoshi Shiraishi; Osamu Kurai
Journal:  JA Clin Rep       Date:  2021-12-14

5.  Modelling the COVID-19 epidemic and the vaccination campaign in Italy by the SUIHTER model.

Authors:  Nicola Parolini; Luca Dede'; Giovanni Ardenghi; Alfio Quarteroni
Journal:  Infect Dis Model       Date:  2022-03-09

Review 6.  Research progress on vaccine efficacy against SARS-CoV-2 variants of concern.

Authors:  Lianlian Bian; Jianyang Liu; Fan Gao; Qiushuang Gao; Qian He; Qunying Mao; Xing Wu; Miao Xu; Zhenglun Liang
Journal:  Hum Vaccin Immunother       Date:  2022-04-19       Impact factor: 4.526

7.  Structures of Omicron spike complexes and implications for neutralizing antibody development.

Authors:  Hangtian Guo; Yan Gao; Tinghan Li; Tingting Li; Yuchi Lu; Le Zheng; Yue Liu; Tingting Yang; Feiyang Luo; Shuyi Song; Wei Wang; Xiuna Yang; Henry C Nguyen; Hongkai Zhang; Ailong Huang; Aishun Jin; Haitao Yang; Zihe Rao; Xiaoyun Ji
Journal:  Cell Rep       Date:  2022-04-15       Impact factor: 9.423

8.  Household Secondary Attack Rates of SARS-CoV-2 by Variant and Vaccination Status: An Updated Systematic Review and Meta-analysis.

Authors:  Zachary J Madewell; Yang Yang; Ira M Longini; M Elizabeth Halloran; Natalie E Dean
Journal:  JAMA Netw Open       Date:  2022-04-01

9.  Household secondary attack rates of SARS-CoV-2 by variant and vaccination status: an updated systematic review and meta-analysis.

Authors:  Zachary J Madewell; Yang Yang; Ira M Longini; M Elizabeth Halloran; Natalie E Dean
Journal:  medRxiv       Date:  2022-01-11

10.  Household transmission of COVID-19 cases associated with SARS-CoV-2 delta variant (B.1.617.2): national case-control study.

Authors:  Hester Allen; Amoolya Vusirikala; Joe Flannagan; Katherine A Twohig; Asad Zaidi; Dimple Chudasama; Theresa Lamagni; Natalie Groves; Charlie Turner; Christopher Rawlinson; Jamie Lopez-Bernal; Ross Harris; Andre Charlett; Gavin Dabrera; Meaghan Kall
Journal:  Lancet Reg Health Eur       Date:  2021-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.